Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 07-2000 | 06-2000 | 04-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,150 | N/A | 4,890 | N/A | 4,220 |
| Marketable Securities | 870 | N/A | 1,040 | N/A | 950 |
| Receivables | 1,010 | N/A | 970 | N/A | 1,480 |
| Inventories | 1,670 | N/A | 1,940 | N/A | 1,780 |
| Other current assets | 960 | 0 | 1,020 | 0 | 960 |
| TOTAL | $7,660 | $N/A | $9,860 | $N/A | $9,390 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 150 | 0 | 150 | 0 | 140 |
| TOTAL | $150 | $N/A | $150 | $N/A | $140 |
| Total Assets | $10,660 | $N/A | $11,890 | $N/A | $10,760 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,190 | 0 | 1,180 | 0 | 1,510 |
| Other current liabilities | 460 | N/A | 1,730 | N/A | 40 |
| TOTAL | $1,720 | $N/A | $2,990 | $N/A | $1,570 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 270 | 0 | 270 | 0 | 270 |
| TOTAL | $270 | $N/A | $270 | $N/A | $270 |
| Total Liabilities | $2,000 | $N/A | $3,260 | $N/A | $1,840 |
| Shareholders' Equity | |||||
| Common Shares | 5 | N/A | 5 | N/A | 5 |
| Retained earnings | 7,840 | N/A | 7,760 | N/A | 7,820 |
| Other shareholders' equity | -925 | 0 | -865 | 0 | -645 |
| TOTAL | $8,650 | $N/A | $8,630 | $N/A | $8,910 |
| Total Liabilities And Equity | $10,650 | $0 | $11,890 | $0 | $10,750 |